United States
Cenduit positions itself as a global leader in IRT systems, specifically tailored for the clinical trial sector, offering solutions in patient randomization, trial supply management (RTSM), and patient engagement. Founded in 2007, the company is positioned at the convergence of Biotechnology, Health Care, and Information Technology industries.
With its slogan, "Accelerating clinical trials through: Quality, Flexibility & Expertise," Cenduit emphasizes its unique value proposition by focusing on offering rapid study startup software and leveraging an expansive global network of over 500 experts. The company's presence spans strategically across the US, UK, Switzerland, India, Japan, and China, ensuring its services reach more than 600,000 patients across 32,000 sites worldwide.
Despite having no recent investment data, the company's established market presence and extensive industry expertise make it a compelling opportunity within the clinical trials landscape for discerning investors.
